securities fraud

Navan IPO investors with losses over $100,000 have until April 24, 2026 to file for lead plaintiff status in a class action alleging the company concealed marketing expense increases before going public.

Ultragenyx faces securities lawsuit over delayed disclosure of failed Phase 3 trial. Investors must file lead plaintiff claims by April 6, 2026.

Kyndryl faces securities lawsuit after disclosing internal control weaknesses and delayed 10-Q filing. Stock dropped 21.8% following CFO and General Counsel departures.

BellRing Brands faces securities lawsuit alleging material non-disclosure from November 2024 to August 2025. Stock fell 52% after two guidance cuts amid retail inventory reductions and competition.

Enphase Energy faces securities class action for alleged disclosure failures. Lead plaintiff deadline is April 20, 2026 for investors with losses exceeding $100,000.

CoreWeave faces securities class action for allegedly omitting material disclosures about operational risks and supply chain vulnerabilities. Investors with losses over $100K must apply by March 13, 2026.

Rosen Law Firm sues Enphase Energy for allegedly making false statements about inventory management and financial guidance. Class action deadline April 20, 2026.

Class action lawsuit filed against uniQure for allegedly making false statements about FDA approval status and BLA submission timelines, misleading investors.

PayPal faces securities fraud lawsuit for allegedly misleading investors about growth targets and revenue outlook. Stock fell 20% after disappointing earnings and CEO departure.

Driven Brands stock plummets 40% after restating financials due to multi-year accounting errors including improper revenue recognition and lease accounting. Securities fraud probe launched.

Corcept Therapeutics faces securities lawsuit alleging it misrepresented relacorilant's FDA approval prospects, causing stock to plunge 50% after regulatory rejection.

AMC faces class action lawsuit alleging it misled investors about Preferred Equity Unit rights, excluding APE holders from a 2023 dividend distribution through undisclosed technical loopholes.

Lakeland Industries faces class action lawsuit alleging executives made false statements about business performance, concealing shipping delays, production issues, and tariffs affecting Pacific Helmets and Jolly segments.

Ardent Health faces class action lawsuit for overstating Q3 2025 revenue and EBITDA guidance by $57.5 million due to inadequate accounting assessments and cost pressures.

Fermi Inc. faces securities class action over alleged false statements regarding Project Matador campus development and undisclosed single-tenant dependency risks.

Four companies face securities fraud class action lawsuits for allegedly making false statements. Investors have until late March 2026 to nominate lead plaintiffs.

Richtech Robotics faces class action lawsuit for allegedly misrepresenting Microsoft partnership. Stock fell 20.9% after Microsoft clarified the relationship wasn't a commercial partnership.

Class action lawsuit filed against China Liberal Education for alleged pump-and-dump scheme. Shareholders who bought stock January 2025-2026 can seek recovery; lead plaintiff deadline is March 31, 2026.

BellRing Brands faces class action lawsuit alleging it misrepresented sales performance by failing to disclose that revenue growth was driven by customer inventory buildup rather than organic demand.

uniQure faces securities fraud lawsuit after FDA rejected its drug candidate AMT-130, causing a 49% stock plunge. Plaintiffs allege the company failed to disclose material information to investors.